When deciding between the **Fidelity MSCI Health Care Index ETF** (FHLC) and the **State Street Health Care Select Sector SPDR ETF** (XLV), investors face an interesting choice. FHLC covers a wider range of company sizes, including mid- and small-cap stocks, while XLV sticks to the healthcare giants of the S&P 500. This means FHLC is better for those seeking more diversity, while XLV may be preferable for those looking for stability and liquidity.
Both ETFs invest in key areas like pharmaceuticals and biotechnology. FHLC, launched in 2013, includes about 365 holdings. In contrast, XLV, which debuted in 1998, focuses on just 60 large-cap stocks.
Cost-wise, both funds have an expense ratio of just 0.08%. However, XLV offers a slightly higher dividend yield at 1.7% compared to FHLC’s 1.4%. This makes XLV attractive to those who prefer immediate income.
Let’s break down some recent performance insights. In the last year (up to May 2026), FHLC delivered an impressive 18.59% return, while XLV returned 16.86%. Interestingly, while FHLC had a max drawdown of 17.70% over five years, XLV’s was slightly lower at 17.10%. Yet, $1,000 invested five years ago in FHLC would now be worth about $1,231, compared to $1,284 for XLV. This illustrates FHLC’s potential for faster growth, albeit with a bit more risk.
The ETF landscape is ever-changing, and as of recent discussions among experts, healthcare remains a hot investment area. According to a 2023 report from the American Investment Council, healthcare investments have grown steadily over the past decade, driven by technological advancements and an aging population. This trend suggests that both FHLC and XLV could offer solid long-term returns as healthcare needs increase.
On social media, conversations about these funds often highlight this very dilemma: diversification versus stability. Investment forums show that many investors lean towards FHLC for its growth potential but also acknowledge the overall reliability of XLV.
In summary, if you favor a more diversified approach to healthcare that includes smaller but potentially high-growth stocks, FHLC might be your choice. On the other hand, if you prefer well-established companies and a higher dividend yield, XLV would likely resonate more. Your financial goals and risk tolerance are key in making the right decision for your portfolio.
